These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25753762)

  • 1. Presentation of meta-analysis plots.
    Wald NJ; Bestwick JP
    J Med Screen; 2015 Mar; 22(1):49-51. PubMed ID: 25753762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal screening for Down's syndrome.
    Wald NJ; Kennard A; Hackshaw A; McGuire A
    J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of an inhibin A ELISA method: implications for Down's syndrome screening.
    Wallace EM; Crossley JA; Ritoe SC; Aitken DA; Spencer K; Groome NP
    Ann Clin Biochem; 1998 Sep; 35 ( Pt 5)():656-64. PubMed ID: 9768333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibin in pregnancy--a new screening marker for prenatal diagnosis?].
    Chada M; Lisá L; Průsa R
    Ceska Gynekol; 2002 Mar; 67(2):93-6. PubMed ID: 11987577
    [No Abstract]   [Full Text] [Related]  

  • 7. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation plots in antenatal screening for Down's syndrome.
    Wald NJ; Bestwick JP; Huttly WJ; Morris JK; George LM
    J Med Screen; 2006; 13(4):166-71. PubMed ID: 17217604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.
    Knight GJ; Palomaki GE; Neveux LM; Haddow JE; Lambert-Messerlian GM
    J Med Screen; 2001; 8(1):2-7. PubMed ID: 11373844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current state of second trimester screening for Down's syndrome.
    Canick JA
    J Med Screen; 1998; 5(3):113-4. PubMed ID: 9795868
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    Wald NJ; Watt HC; Hackshaw AK
    N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
    Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL
    J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome.
    Spencer K; Wood PJ; Anthony FW
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():219-20. PubMed ID: 8466163
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M; Nørgaard-Pedersen B
    Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel chemiluminescent imaging microtiter plates for high-throughput detection of multiple serum biomarkers related to Down's syndrome via soybean peroxidase as label enzyme.
    Zhao F; Chai D; Lu J; Yu J; Liu S
    Anal Bioanal Chem; 2015 Aug; 407(20):6117-26. PubMed ID: 26105511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
    Wald NJ; Morris JK; Ibison J; Wu T; George LM
    Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screening.
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12420332
    [No Abstract]   [Full Text] [Related]  

  • 20. Antenatal screening for Down's syndrome with the quadruple test.
    Wald NJ; Huttly WJ; Hackshaw AK
    Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.